Molecular characterization of PXA tumors has identified a common missense mutation (V600E) in the BRAF kinase gene that may be a driving mutation, present in roughly two-thirds of PXA tumors [17], making BRAF molecular profiling an important diagnostic tool for PXA. The gene discussed is BRAF; the disease is pleomorphic xanthoastrocytoma.